TITLE

PREVALENCE OF HCV INFECTION IN PATIENTS ON HAEMODIALYSIS: SURVEY BY ANTIBODY AND CORE ANTIGEN DETECTION

AUTHOR(S)
Reddy, A. K.; Murthy, K. V. D.; Lakshmi, V.
PUB. DATE
April 2005
SOURCE
Indian Journal of Medical Microbiology;Apr2005, Vol. 23 Issue 2, p106
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: The present study was undertaken to determine the prevalence of HCV infection by antibody testing and HCV core antigen (HCVcAg) determination by ELISA in haemodialysis patients and to evaluate the HCV c Ag assay in the detection of HCV infected patients on haemodialysis. Materials and Methods: A total of 151 chronic renal failure patients on haemodialysis from May 2003 to October 2004 were studied. One hundred patients out of 151 were followed for 2-5 months. All the patients were tested for anti HCV and HCV core antigen once a month. Anti HCV ELISA positive specimens were confirmed by RIBA.. Results: The overall prevalence of HCV infection was 13.23%. Antibody positivity was observed in 9.93% and HCVcAg alone was detected in 2.64%. One patient (0.66%) was initially positive for core antigen and later seroconverted. Conclusions: Screening for HCV antibodies alone does not exclude infection with HCV in patients on haemodialysis and HCVcAg may be a useful test for identifying HCV infected patients on haemodialysis in the early phase of infection before seroconversion.
ACCESSION #
18078570

 

Related Articles

  • Hepatitis C in dialysis units. Quiroz, Rolando José Ortega // Revista Colombiana de Gastroenterología;Mar2010, Vol. 25 Issue 1, p4 

    The author reflects on the treatment of Hepatitis C virus (HCV) in dialysis units. He considers the amount of time a patient spends in hemodialysis units as the primary risk factor for Hepatitis C infection acquisition. He points out that HCV's natural history in patients with chronic renal...

  • Epidemiology of CKD and dialysis 1.  // Nephrology Dialysis Transplantation;Jul2007 Supplement 6, Vol. 22, pvi190 

    This section presents abstracts on nephrology-related topics including the link between asymmetrical dimethyl arginine and mortality in patients with end-stage renal disease, prevalence of occult hepatitis C virus (HCV) infection in hemodialysis patients and the incidence of cancer among...

  • Clinical Presentation of Chronic Hepatitis C in Patients with End-Stage Renal Disease and on Hemodialysis Versus Those with Normal Renal Function. Hu, Ke-Qin; Lee, Steve M; Hu, Shirley X.; Xia, Victor W.; Hillebrand, Donald J.; Kyulo, Namgyal L. // American Journal of Gastroenterology;Sep2005, Vol. 100 Issue 9, p2010 

    BACKGROUND: The natural history of chronic hepatitis C (CHC) remains to be defined in patients with end-stage renal disease (ESRD). AIMS: To determine the clinical presentation of CHC and the factors associated with stage III-IV fibrosis in patients with CHC and ESRD. METHODS: The study included...

  • Evidence of association between hepatitis C virus genotype 2b and nosocomial transmissions in hemodialysis centers from southern Brazil. da Silva, Naylê Maria Oliveira; Germano, Fabiana Nunes; Mendoza-Sassi, Raul Andres; Seuánez, Hector Nicolas; Soares, Marcelo Alves; de Martinez, Ana Maria Barral // Virology Journal;2013, Vol. 10 Issue 1, p1 

    Background: Hepatitis C virus infection is a serious public health problem. Hemodialysis is considered one of the main risk factors of HCV infection, due to several invasive medical procedures and potential nosocomial transmission that patients with chronic renal failure (CRF) are continuously...

  • UTILITY OF HCV CORE ANTIGEN ELISA IN THE SCREENING FOR HEPATITIS C VIRUS INFECTION IN PATIENTS ON HEMODIALYSIS. Reddy, A. K.; Dakshinamurty, K. V.; Lakshmi, V. // Indian Journal of Medical Microbiology;Jan2006, Vol. 24 Issue 1, p55 

    An enzyme immuno assay for hepatitis C core antigen was recently developed and its performance was compared with that of the hepatitis C virus (HCV) RNA in the screening of HCV infection in patients on hemodialysis. One hundred and eleven chronic renal failure patients undergoing haemodialysis...

  • Hepatitis C virus infection in dialysis and renal transplantation. Pereira, Brian J. G.; Levey, Andrew S. // Kidney International;Apr1997, Vol. 51 Issue 4, p981 

    This article focuses on medical complexities associated with hepatitis C virus infections in dialysis and renal transplantation. Liver failure is, reportedly, the cause of death in 8 to 28% of long-term survivors after renal transplantation. In the past, approximately half of these cases of...

  • Prevalencia de anticuerpos contra el virus de hepatitis C en unidades de diálisis de Cali-Colombia. Ramírez, Roberto; Fernández, Julián; Guevara, Juan Guillermo; Valderrama, Luis Alfonso; Castro, Adolfo León; Álvarez, Javier Arango; Holguín, R. Jaime // Revista Colombiana de Gastroenterología;Mar2010, Vol. 25 Issue 1, p14 

    The prevalence of anti-HCV antibodies among patients on dialysis is consistently higher than in healthy populations, suggesting that dialysis patients may be at higher risk of acquiring HCV infection. The aim of our study was to determinate the prevalence of anti-HCV antibodies in patients whom...

  • Novel Evolved Immunoglobulin (Ig)-Binding Molecules Enhance the Detection of IgM against Hepatitis C Virus. Jie Cao; Qiuli Chen; Huaqun Zhang; Peipei Qi; Chao Liu; Xufang Yang; Niansong Wang; Baohua Qian; Jinhong Wang; Shaohua Jiang; Hua Yang; Shuhan Sun; Wei Pan // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Detection of specific antibodies against hepatitis C virus (HCV) is the most widely available test for viral diagnosis and monitoring of HCV infections. However, narrowing the serologic window of anti-HCV detection by enhancing anti-HCV IgM detection has remained to be a problem. Herein, we used...

  • Undiagnosed hepatitis C virus infection in hemodialysis patients: Value of HCV RNA and liver enzyme levels. Caramelo, Carlos; Bartolomé, Javier; Albalate, Marta; de Sequera, Patricia; Navas, Sonia; Bermejillo, Teresa; Oliva, Horacio; Marriott, Eduardo; Ortiz, Alberto; Tuñón, Carmen Ruiz; Casado, Santos; Carreño, Vicente // Kidney International;Dec1996, Vol. 50 Issue 6, p2027 

    At present, routine screening for hepatitis C virus (HCV) infection is based on the detection of antiviral antibodies. Underdiagnosis of HCV infection by using HCV antibody tests, however, still occurs. Additional diagnostic means are provided by the polymerase chain reaction (PCR). The...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics